Home/ Stocks/ ILMN

Illumina Inc

ILMN XNAS

$222.29 +1.10 (+0.49%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$33.57B

About Illumina Inc

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 8.7K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2027	$1.16B	$207.00M	$1.37
Q4 2026	$1.09B	$134.00M	$0.88
FY 2025	$4.34B	$850.00M	$5.47
Q3 2025	$1.08B	$150.00M	$0.98

Related Market News

No specific coverage for ILMN yet. Check out our latest market news or earnings calendar.

Get ILMN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Illumina Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.